LRRK2 Modulates the Exocyst Complex Assembly by Interacting with Sec8.
LRRK2
Parkinson’s disease
Sec8
exocyst complex
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
20 01 2021
20 01 2021
Historique:
received:
28
10
2020
revised:
12
01
2021
accepted:
18
01
2021
entrez:
27
1
2021
pubmed:
28
1
2021
medline:
13
10
2021
Statut:
epublish
Résumé
Mutations in LRRK2 play a critical role in both familial and sporadic Parkinson's disease (PD). Up to date, the role of LRRK2 in PD onset and progression remains largely unknown. However, experimental evidence highlights a critical role of LRRK2 in the control of vesicle trafficking, likely by Rab phosphorylation, that in turn may regulate different aspects of neuronal physiology. Here we show that LRRK2 interacts with Sec8, one of eight subunits of the exocyst complex. The exocyst complex is an evolutionarily conserved multisubunit protein complex mainly involved in tethering secretory vesicles to the plasma membrane and implicated in the regulation of multiple biological processes modulated by vesicle trafficking. Interestingly, Rabs and exocyst complex belong to the same protein network. Our experimental evidence indicates that LRRK2 kinase activity or the presence of the LRRK2 kinase domain regulate the assembly of exocyst subunits and that the over-expression of Sec8 significantly rescues the LRRK2 G2019S mutant pathological effect. Our findings strongly suggest an interesting molecular mechanism by which LRRK2 could modulate vesicle trafficking and may have important implications to decode the complex role that LRRK2 plays in neuronal physiology.
Identifiants
pubmed: 33498474
pii: cells10020203
doi: 10.3390/cells10020203
pmc: PMC7909581
pii:
doi:
Substances chimiques
EXOC4 protein, human
0
Exoc4 protein, rat
0
Membrane Proteins
0
Multiprotein Complexes
0
Sec8l1 protein, mouse
0
Vesicular Transport Proteins
0
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
EC 2.7.11.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Michael J. Fox Foundation for Parkinson's Research
ID : LRRK2 Challenge 2014 ID9550
Organisme : Fondazione Banco di Sardegna
ID : 2014.0489
Organisme : Regione Sardegna
ID : CRP-78083
Organisme : NIH HHS
ID : P50 NS38377
Pays : United States
Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : PON 2014-2020 (CCI2014IT16M2OP005)
Références
Front Cell Dev Biol. 2016 Apr 12;4:24
pubmed: 27148529
EMBO J. 2014 Oct 16;33(20):2314-31
pubmed: 25201882
Neuron. 2004 Nov 18;44(4):595-600
pubmed: 15541308
Elife. 2016 Jan 29;5:
pubmed: 26824392
Biosci Rep. 2009 Aug;29(4):229-35
pubmed: 19006485
J Biol Chem. 2014 Jan 10;289(2):895-908
pubmed: 24275654
Hum Mol Genet. 2015 Mar 1;24(5):1336-49
pubmed: 25343991
PLoS One. 2017 Jun 5;12(6):e0179082
pubmed: 28582422
Neurobiol Dis. 2011 Sep;43(3):642-50
pubmed: 21624464
Elife. 2017 Sep 20;6:
pubmed: 28930069
Mol Biol Cell. 2007 Nov;18(11):4483-92
pubmed: 17761530
Dev Neurobiol. 2012 Jan;72(1):134-44
pubmed: 21563316
J Cell Sci. 2015 Aug 15;128(16):2957-64
pubmed: 26240175
J Biochem. 2015 Jun;157(6):485-95
pubmed: 25605758
J Neurosci. 2018 Sep 12;38(37):8071-8086
pubmed: 30209205
J Cell Sci. 2006 Mar 1;119(Pt 5):807-18
pubmed: 16478790
Dev Biol. 1997 Dec 15;192(2):364-74
pubmed: 9441674
Biochem Soc Trans. 2012 Oct;40(5):1117-22
pubmed: 22988875
Neurosci Lett. 2019 Apr 1;697:59-65
pubmed: 29627340
Mol Biol Cell. 2012 Jan;23(2):337-46
pubmed: 22114349
Nat Commun. 2014 Oct 15;5:5245
pubmed: 25316291
Neuron. 2013 Feb 6;77(3):425-39
pubmed: 23395371
J Neurochem. 2015 Dec;135(6):1242-56
pubmed: 26375402
Am J Physiol Renal Physiol. 2010 Sep;299(3):F495-506
pubmed: 20576682
J Neurosci. 2011 Feb 9;31(6):2225-37
pubmed: 21307259
Neuron. 1996 Dec;17(6):1209-19
pubmed: 8982167
Trends Cell Biol. 2011 Jul;21(7):383-6
pubmed: 21550243
Neuron. 2004 Nov 18;44(4):601-7
pubmed: 15541309
Nat Struct Mol Biol. 2016 Jan;23(1):59-66
pubmed: 26656853
Neuron. 2012 Sep 20;75(6):1008-21
pubmed: 22998870
PLoS Genet. 2015 Sep 22;11(9):e1005484
pubmed: 26394140
J Neurosci. 2017 Nov 22;37(47):11366-11376
pubmed: 29054882
J Cell Mol Med. 2019 Dec;23(12):8505-8510
pubmed: 31560168
J Cell Biol. 2001 Nov 12;155(4):593-604
pubmed: 11696560
Hum Mol Genet. 2012 Mar 15;21(6):1350-63
pubmed: 22171073
J Neurosci. 2011 Mar 9;31(10):3522-35
pubmed: 21389209
Nat Neurosci. 2014 Mar;17(3):367-76
pubmed: 24464040
Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):E41-50
pubmed: 26607451
J Cell Physiol. 2017 May;232(5):939-957
pubmed: 27669116
Biochim Biophys Acta. 2015 Jul;1848(7):1481-9
pubmed: 25838123
Biochem J. 2003 Jul 1;373(Pt 1):49-55
pubmed: 12675619
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2626-31
pubmed: 24510904
Hum Mol Genet. 2007 Jun 1;16(11):1319-26
pubmed: 17409193
Nat Cell Biol. 2003 Jun;5(6):520-30
pubmed: 12738960
Nat Rev Neurosci. 2010 Dec;11(12):791-7
pubmed: 21088684
Mol Neurobiol. 2019 Jul;56(7):4620-4638
pubmed: 30374940
Lancet Neurol. 2008 Jul;7(7):583-90
pubmed: 18539534
Mol Neurodegener. 2016 Jan 13;11:1
pubmed: 26758690
Neuron. 2003 Feb 6;37(3):433-47
pubmed: 12575951
J Cell Sci. 2007 Aug 1;120(Pt 15):2694-705
pubmed: 17635999
J Cell Biol. 2005 Aug 15;170(4):583-94
pubmed: 16103227
J Neurosci. 2016 Jul 6;36(27):7128-41
pubmed: 27383589
PLoS One. 2013 Oct 22;8(10):e77198
pubmed: 24167564
Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):1635-1640
pubmed: 29386392
Nat Struct Mol Biol. 2005 Oct;12(10):879-85
pubmed: 16155582
J Neurosci. 2001 Jun 1;21(11):3839-48
pubmed: 11356872
EMBO J. 2007 Sep 19;26(18):4053-65
pubmed: 17717527
Biochem J. 2007 Jul 15;405(2):307-17
pubmed: 17447891